TherapeuticsMD Inc expected to post a loss of $3.04 a share - Earnings Preview

TherapeuticsMD

29/07/2022 15:50

* TherapeuticsMD Inc  TXMD.OQ   TXMD.O  is expected to show
a rise
in quarterly revenue when it reports  results on August 2
(estimated). 
    * The Boca Raton Florida-based  company is expected to
report  a
0.9% increase in revenue to $23.2 million from $23 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for TherapeuticsMD Inc
is for
a loss of $3.04 per share. For the same quarter last year, the
company reported a loss of $5.50 per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
TherapeuticsMD
Inc is $65​, above​ its last closing price of $6.00. ​​​

This summary was machine generated July 29 at 14:50 GMT.  All
figures in US dollars  unless otherwise stated